Results 171 to 180 of about 325,686 (199)

SerpinA3 is an Endogenous TGF‐β Receptor Antagonist that Attenuates Cardiac Fibroblast Activation and Fibrotic Remodeling

open access: yesAdvanced Science, EarlyView.
SerpinA3 acts as an endogenous TGF‐β receptor antagonist that binds to the extracellular domain of TGFR‐1, thereby preventing TGFR‐1–TGFR‐2 complex formation. This receptor‐level blockade suppresses TGF‐β/Smad2/3 signaling, attenuates cardiac fibroblast activation, and extracellular matrix deposition, and ultimately alleviates pressure overload–induced
Hui Wang   +9 more
wiley   +1 more source

Polypharmacological target-aware molecule generation. [PDF]

open access: yesBioinformatics
Wu K   +10 more
europepmc   +1 more source

Antibodies vs. aptamers in cancer diagnosis and therapy: a comparative analysis of clinical applications, mechanisms, and future directions. [PDF]

open access: yesAnn Med Surg (Lond)
Beniwal SS   +10 more
europepmc   +1 more source

Co-VAE: Drug-Target Binding Affinity Prediction by Co-Regularized Variational Autoencoders

IEEE Transactions on Pattern Analysis and Machine Intelligence, 2022
Xing-Ming Zhao, Limin Li, Tianjiao Li
exaly  

Home - About - Disclaimer - Privacy